One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
A call to adapt the regulation of HLA testing for T cell receptor-based therapeutics
By Miriam Meyer, Andrea Mahr, Joanna Brewer, Volker Daniel, Justine Dell‘Aringa, Tony Goldstone, Sarah Hersey, Ian Johnston, Pamela Larson, Michael Loveridge, Gavin MacBeath, Mark Moyer, Dirk Nagorsen, Sophie Papa, Leanne Peiser, Koustubh Ranade, Ruben Rizzi, Axel Roers, Dolores Schendel, Pallavur Sivakumar, Eric Tran, Özlem Türeci, Luise Weigand, Anders Wennborg, … Cedrik M. Britten
doi : 10.1038/d41573-023-00189-4
Volume 23 Issue 1, January 2024
Tumour-infiltrating lymphocyte cancer therapy nears FDA finish line
By Asher Mullard
De-risking rare disease acquisitions: a win–win–win for patients, biotech and investors
By James A. Levine & Clea Stemitsiotis
CRISPR gets the glory in landmark approval, but haemoglobin research made it possible
By Asher Mullard
Gene therapy zeroes in on Parkinson disease brain circuits
By Katie Kingwell
Targeting synapse function and loss for treatment of neurodegenerative diseases
Borislav Dejanovic, Morgan Sheng & Jesse E. HansonÂ
Drugging the NLRP3 inflammasome: from signalling mechanisms to therapeutic targets
Lieselotte Vande Walle & Mohamed LamkanfiÂ
Tailor made: the art of therapeutic mRNA design
Mihir Metkar, Christopher S. Pepin & Melissa J. MooreÂ
